Park J, Hwang Y, Na H, Kim D, Lee H, Kwon T
J Pharmacopuncture. 2025; 27(4):332-339.
PMID: 39741567
PMC: 11656058.
DOI: 10.3831/KPI.2024.27.4.332.
Murray C, Gannon B, Winsauer P, Cooper Z, Delatte M
Pharmacol Rev. 2024; 76(5):915-955.
PMID: 38849155
PMC: 11331953.
DOI: 10.1124/pharmrev.123.001121.
Caprari C, Ferri E, Vandelli M, Citti C, Cannazza G
J Cannabis Res. 2024; 6(1):21.
PMID: 38702834
PMC: 11067227.
DOI: 10.1186/s42238-024-00226-y.
Tanaka R, Kikura-Hanajiri R
Forensic Toxicol. 2023; 42(1):71-81.
PMID: 37365398
DOI: 10.1007/s11419-023-00667-9.
Calapai F, Cardia L, Esposito E, Ammendolia I, Mondello C, Lo Giudice R
Evid Based Complement Alternat Med. 2022; 2022:3336516.
PMID: 36397993
PMC: 9666035.
DOI: 10.1155/2022/3336516.
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?.
Filipiuc L, Ababei D, Alexa-Stratulat T, Pricope C, Bild V, Stefanescu R
Pharmaceutics. 2021; 13(11).
PMID: 34834237
PMC: 8625816.
DOI: 10.3390/pharmaceutics13111823.
Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms.
Russo E, Cuttler C, Cooper Z, Stueber A, Whiteley V, Sexton M
Cannabis Cannabinoid Res. 2021; 7(5):706-716.
PMID: 34569849
PMC: 9587780.
DOI: 10.1089/can.2021.0058.
Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances.
Farrelly A, Vlachou S, Grintzalis K
Int J Environ Res Public Health. 2021; 18(8).
PMID: 33920188
PMC: 8070313.
DOI: 10.3390/ijerph18083993.
Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals.
Petrunich-Rutherford M, Calik M
Adv Exp Med Biol. 2021; 1297:97-109.
PMID: 33537939
DOI: 10.1007/978-3-030-61663-2_7.
Constituents of Cannabis Sativa.
Rock E, Parker L
Adv Exp Med Biol. 2020; 1264:1-13.
PMID: 33332000
DOI: 10.1007/978-3-030-57369-0_1.
Effect of combined doses of Δ-tetrahydrocannabinol and cannabidiol or tetrahydrocannabinolic acid and cannabidiolic acid on acute nausea in male Sprague-Dawley rats.
Rock E, Sullivan M, Pravato S, Pratt M, Limebeer C, Parker L
Psychopharmacology (Berl). 2020; 237(3):901-914.
PMID: 31897571
DOI: 10.1007/s00213-019-05428-4.
Functional characterization of the cannabinoid receptors 1 and 2 in zebrafish larvae using behavioral analysis.
Luchtenburg F, Schaaf M, Richardson M
Psychopharmacology (Berl). 2019; 236(7):2049-2058.
PMID: 30820632
PMC: 6647118.
DOI: 10.1007/s00213-019-05193-4.
Cannabigerol Action at Cannabinoid CB and CB Receptors and at CB-CB Heteroreceptor Complexes.
Navarro G, Varani K, Reyes-Resina I, Sanchez de Medina V, Rivas-Santisteban R, Sanchez-Carnerero Callado C
Front Pharmacol. 2018; 9:632.
PMID: 29977202
PMC: 6021502.
DOI: 10.3389/fphar.2018.00632.
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ-Tetrahydrocannabinol.
Boggs D, Nguyen J, Morgenson D, Taffe M, Ranganathan M
Neuropsychopharmacology. 2017; 43(1):142-154.
PMID: 28875990
PMC: 5719112.
DOI: 10.1038/npp.2017.209.
Anticipatory nausea in animal models: a review of potential novel therapeutic treatments.
Rock E, Limebeer C, Parker L
Exp Brain Res. 2014; 232(8):2511-34.
PMID: 24792499
DOI: 10.1007/s00221-014-3942-9.
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system.
Sharkey K, Darmani N, Parker L
Eur J Pharmacol. 2013; 722:134-46.
PMID: 24184696
PMC: 3883513.
DOI: 10.1016/j.ejphar.2013.09.068.
Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.
Rock E, Kopstick R, Limebeer C, Parker L
Br J Pharmacol. 2013; 170(3):641-8.
PMID: 23889598
PMC: 3792001.
DOI: 10.1111/bph.12316.
Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist.
Cascio M, Gauson L, Stevenson L, Ross R, Pertwee R
Br J Pharmacol. 2009; 159(1):129-41.
PMID: 20002104
PMC: 2823359.
DOI: 10.1111/j.1476-5381.2009.00515.x.
Investigations on behavioral effects of an extract of Cannabis sativa L. in the rat.
Ferri S, Costa G, MURARI G, Panico A, Rapisarda E, Speroni E
Psychopharmacology (Berl). 1981; 75(2):144-7.
PMID: 6798604
DOI: 10.1007/BF00432176.
Increased resistance-to-extinction of an avoidance response in rats following the administration of hashish resin.
Jaffe P, Baum M
Psychopharmacologia. 1971; 20(1):97-102.
PMID: 5565750
DOI: 10.1007/BF00404064.
